Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 10.89M $85.30M March 31, 2015
T. Rowe Price Associates 6.61M $51.78M March 31, 2015
BlackRock Fund Advisors 4.99M $39.04M March 31, 2015
STATE STREET CORPORATION 4.97M $38.89M March 31, 2015
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
Foresite Capital Management II 4.20M $32.89M March 31, 2015
Vanguard 3.79M $29.66M March 31, 2015
NEA Management Company 3.71M $29.04M March 31, 2015
Capital Research Global Investors^ 3.62M $28.34M March 31, 2015
Franklin Resources 3.45M $26.98M March 31, 2015
BlackRock Institutional Trust Company, N.A. 3.20M $25.06M March 31, 2015
Samlyn Capital 3.14M $24.57M March 31, 2015
Scale Management 3.02M $18.29M Dec. 31, 2014
Partner Fund Management 2.87M $22.48M March 31, 2015
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Farallon Capital Management 2.68M $17.45M March 31, 2014
Deutsche Bank Aktiengesellschaft 2.62M $0 March 31, 2015
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
Millennium Management 2.50M $19.56M March 31, 2015
MORGAN STANLEY 2.31M $14.01M Dec. 31, 2014
RS INVESTMENT MANAGEMENT 2.23M $9.50M Sept. 30, 2014
Meditor 2.10M $12.87M Sept. 30, 2013
Point72 Asset Management 2.05M $16.04M March 31, 2015
QVT Financial 1.99M $7.35M March 31, 2012
Palo Alto Investors 1.93M $15.12M March 31, 2015
Lamond Capital Partners 1.89M $11.46M Dec. 31, 2014
Bank of America Corporation 1.87M $11.19M Dec. 31, 2014
CQS Cayman Limited Partnership 1.82M $14.27M March 31, 2015
FRED ALGER MANAGEMENT 1.78M $11.57M March 31, 2014
COLUMBIA PARTNERS L L C INVESTMENT MANAGEMENT 1.70M $7.24M Sept. 30, 2014
FIL 1.70M $13.29M March 31, 2015
Rock Springs Capital Management 1.69M $10.21M Dec. 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.68M $13.15M March 31, 2015
Visium Asset Management 1.67M $9.77M June 30, 2013

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M